STALLION NSE filing

Stallion India Fluorochemicals starts R-32 facility groundwork in Bhilwara

The RealCase readMedium impact Positive

Stallion India Fluorochemicals begins groundwork for its R-32 manufacturing facility in Bhilwara, Rajasthan, with construction starting 1st November 2025 and commissioning targeted by July 2026.

Why it matters

The new facility represents a significant investment and is expected to contribute substantially to the company's revenue and profitability upon completion.

The market read

The announcement details the commencement of a new manufacturing facility, which is expected to boost the company's topline and profitability.

* Stallion India Fluorochemicals Limited (SIFL) has commenced groundwork for its 10,000 MT R-32 manufacturing facility in Bhilwara, Rajasthan, with a Bhoomi Pooja ceremony held on 19th October 2025. * Key contracting and technology transfer arrangements are finalized, with construction starting on 1st November 2025. * The project involves an investment of around ₹200 crores and is targeted for completion within nine months, with commissioning by July 2026. * Once operational, it is expected to generate a topline of approximately ₹500 crores with a PAT margin in the range of 22–24%. * Mr. Shazad Rustomji, MD & CEO, stated that the Bhilwara facility is a major step towards backward integration and self-reliance in fluorochemicals manufacturing, providing strategic control over key raw materials.

Filing to action

What to do with a filing like this

Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under capex. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.

View original filing